scholarly journals Celebrating one year anniversary of Contemporary Pediatric Dentistry and introducing the new Congress

2021 ◽  
Vol 2 (3) ◽  
pp. 134-134
Author(s):  
Burak Buldur

Hi Dear Friends and Colleagues, I am pleased to inform you some of good news regarding the development and process of the Contemporary Pediatric Dentistry (CPD). Since its establishment, CPD has received 80 submissions from all over world within sixteen months, and published 25 articles including review, original research and case reports. CPD has also moved to be indexed in reputed databases. Another achievement was establishment of 1st International Congress of Contemporary Pediatric Dentistry (ICCPD), organized by the CPD, which was taken place on 1- 3 November 2021 as a fully virtual meeting to celebrate the first anniversary of the launch of CPD. The ICCPD hosted 257 registered colleagues from 47 countries. The website of the ICCPD had been viewed more than 5000 visitors from 102 countries in only 2 months. As an exciting action, CPD is now getting ready to initiate the 2nd International Congress of Contemporary Pediatric Dentistry (www.iccpd.org). I feel confident that the ICCPD 2022 will serve as a place of learning where we can all share the latest knowledge and learn the contemporary view, approaches, techniques and treatment options from highly eminent clinicians and/or academicians from different countries. The theme of the ICCPD 2022 is “Contemporary Clinical Techniques in Pediatric Dentistry”. The 2nd ICCPD will also host oral and poster presentation. All abstracts will be published in the Supplementary Issue of Contemporary Pediatric Dentistry. It is my honor to invite all colleagues, who have sincere enthusiasm to help children to let them have better oral health, quality of life, smiling and development, to attend 2nd International Congress of Contemporary Pediatric Dentistry to be held on 2-4 September 2022 as a fully virtual meeting. Please follow website and social media accounts of CPD to get latest information regarding Congress and the Journal.

Author(s):  
Mirja Möhn ◽  
Julia Camilla Bulski ◽  
Norbert Krämer ◽  
Alexander Rahman ◽  
Nelly Schulz-Weidner

Amelogenesis imperfecta (AI) is defined as an interruption of enamel formation due to genetic inheritance. To prevent malfunction of the masticatory system and an unaesthetic appearance, various treatment options are described. While restoration with a compomer in the anterior region and stainless steel crowns in the posterior region is recommended for deciduous dentition, the challenges when treating such structural defects in mixed or permanent dentition are changing teeth and growing jaw, allowing only temporary restoration. The purpose of this case report is to demonstrate oral rehabilitation from mixed to permanent dentition. The dentition of a 7-year-old patient with AI type I and a 12-year-old patient with AI type II was restored under general anesthesia to improve their poor aesthetics and increase vertical dimension, which are related to problems with self-confidence and reduced oral health quality of life. These two cases show the complexity of dental care for structural anomalies of genetic origin and the challenges in rehabilitating the different phases of dentition.


2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Trisha Plastini ◽  
Arthur Staddon

Sertoli-Leydig Cell Tumors (SLCTs) make up <1% of all ovarian tumors and are benign or malignant, androgen-secreting tumors. Rhabdomyosarcoma (RMS) is a heterogeneous group of malignant tumors that resemble developing skeletal muscle. There have been case reports of patients with concurrent SLCT and RMS with limited treatment options. We aim to demonstrate treatment strategies used in our patients, which seemed to have prolonged survival when compared to prior case reports of patients not cured by surgical resection. Herein we describe 22 cases of SLCT with RMS elements as discussed in prior case reports and three cases from the authors’ institution. Of the 19 cases from prior case reports, five were lost to follow-up and two had NED after surgical intervention. Eleven patients had recurrence and were deceased within one year. Of those patients not surgically cured, only three patients were documented as living beyond two years, all of whom received chemotherapy. The three patients presented from our institution had clinical evidence of response to chemotherapy that is traditionally used for RMS. In conclusion, chemotherapy with doxorubicin and ifosfamide has activity in patients with SLCT and RMS as does salvage chemotherapy with vincristine, irinotecan, and temozolomide.


2017 ◽  
Vol 8 (3) ◽  
pp. ar.2017.8.0210 ◽  
Author(s):  
Lauren W. Kaminsky ◽  
Theodore Kelbel ◽  
Fay Ansary ◽  
Timothy Craig

Background Hereditary angioedema (HAE) is a life-long disease that often manifests by puberty. Treatment of attacks is essential to improve quality of life and to decrease morbidity and mortality. During pregnancy, treatment is limited because multiple treatment options, including icatibant, are not approved for use during pregnancy. Objective We report the outcomes of three pregnancies during which icatibant was used by a patient with HAE with normal C1-inhibitor for treatment of attacks. We also reviewed the literature for reports of icatibant use during pregnancy for outcomes and adverse events. Methods We report on a patient who treated herself with icatibant during three separate pregnancies. Postpartum follow-up verified the health of the mother and children. We also performed a complete literature search of medical literature data bases on icatibant use during pregnancy. Results The patient in our report administered multiple doses of icatibant during three pregnancies. The child born from the first pregnancy and the child from the third pregnancy were born at term and without congenital anomalies. The child from the second pregnancy was 1-month preterm. All three children were developmentally normal. The literature search identified two case reports and one abstract of limited icatibant use without adverse events during pregnancy in patients with HAE. These pregnancies resulted in the births of healthy infants. Conclusion From a search of the literature, three cases of icatibant use during pregnancy resulted in healthy infants. In addition, we report that from icatibant use in three separate pregnancies, one infant was born prematurely, but there were no birth defects. From follow-up, the children continued meeting developmental milestones. This report adds to the acquisition of knowledge for drug adverse events during postmarketing surveillance for icatibant use during pregnancy.


Vascular ◽  
2014 ◽  
Vol 23 (2) ◽  
pp. 204-210 ◽  
Author(s):  
P Del Canto Peruyera ◽  
MJ Vallina-Victorero Vázquez ◽  
M Botas Velasco ◽  
P Calvín Álvarez ◽  
A Álvarez Salgado ◽  
...  

Two cases of cystic adventitial disease treated at our institution over the last year are presented. They were middle-aged and apparently healthy patients, and the symptoms begin with a sudden onset of unilateral claudication. After performing a magnetic resonance angiography, a cystic formation attached to the adventitia of the popliteal artery was identified. Both patients were treated in the same manner, with resection of the affected arterial segment and vein bypass interposition. Both remain asymptomatic after one year of follow-up in one case and six months in the other. Cystic adventitial disease is a rare entity, which presents in patients without cardiovascular risk factors, so sometimes it takes long to reach a definitive diagnosis. Concerning the different treatment options, cyst excision together with the affected arterial segment seems to offer better mid- and long-term results when compared with other treatment options such as cyst aspiration or endovascular techniques, although there are no multicenter trials evidencing the superiority of one against the others.


Author(s):  
Alexander Gross ◽  
Thomas Albrecht

Background Since its outbreak in December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has infected more than 151 million people worldwide. More than 3.1 million have died from Coronavirus Disease 2019 (COVID-19), the illness caused by SARS-CoV-2. The virus affects mainly the upper respiratory tract and the lungs causing pneumonias of varying severity. Moreover, via direct and indirect pathogenetic mechanisms, SARS-CoV-2 may lead to a variety of extrapulmonary as well as vascular manifestations. Methods Based on a systematic literature search via PubMed, original research articles, meta-analyses, reviews, and case reports representing the current scientific knowledge regarding diagnostic imaging of COVID-19 were selected. Focusing on the imaging appearance of pulmonary and extrapulmonary manifestations as well as indications for imaging, these data were summarized in the present review article and correlated with basic pathophysiologic mechanisms. Results and Conclusion Typical signs of COVID-19 pneumonia are multifocal, mostly bilateral, rounded, polycyclic or geographic ground-glass opacities and/or consolidations with mainly peripheral distribution. In severe cases, peribronchovascular lung zones are affected as well. Other typical signs are the “crazy paving” pattern and the halo and reversed halo (the latter two being less common). Venous thromboembolism (and pulmonary embolism in particular) is the most frequent vascular complication of COVID-19. However, arterial thromboembolic events like ischemic strokes, myocardial infarctions, and systemic arterial emboli also occur at higher rates. The most frequent extrapulmonary organ manifestations of COVID-19 affect the central nervous system, the heart, the hepatobiliary system, and the gastrointestinal tract. Usually, they can be visualized in imaging studies as well. The most important imaging modality for COVID-19 is chest CT. Its main purpose is not to make the primary diagnosis, but to differentiate COVID-19 from other (pulmonary) pathologies, to estimate disease severity, and to detect concomitant diseases and complications. Key Points:  Citation Format


2012 ◽  
Vol 3 (4) ◽  
Author(s):  
Thomas L. Lenz ◽  
Nicole D. Gillespie ◽  
Maryann Z. Skrabal ◽  
Michele A. Faulkner ◽  
Jessica J. Skradski ◽  
...  

Health related quality of life (HRQOL) and self-perceived well-being have been shown to be associated with lower healthcare utilization and costs in people with chronic diseases. A pharmacist-run employee health program started in 2008 sought to improve HRQOL through the use of individualized lifestyle behavior programming, medication therapy management, and care coordination activities. Following one year of participation in the program, employee participant's self-reported general health rating significantly improved compared with their baseline rating (p < 0.001). Participants also reported a significantly lower number of days within a month when they did not feel physically and/or mentally well at baseline vs. one-year, respectively (10.3 days vs. 6.0 days, p < 0.01). Pharmacists can positively impact self-reported HRQOL when working in an employee health setting.   Type: Original Research


Author(s):  
Louise Shewan ◽  
Michael Henein ◽  
Andrew Coats

<p class="normal">This special issue includes expert reviews and original research on Takotsubo syndrome (TTS) including the history of its identification and the unravelling of the pathophysiology of the different variants of the syndrome. The role of neurological stress or catecholaminergic overload are reviewed, as is the role of CNS disorders triggering TTS. Clinical presentation patterns of TTS and the most useful diagnostic tests are reviewed, including original research into a novel clinical score the ‘GET QT' score to help in rapid differentiation of TTS from STEMI. There is also a review of TTS in the intensive care unit setting.  The mechanisms of TTS including the role and assessment of the microcirculation in generating the classical myocardial dysfunction are reviewed in detail, as are the pathophysiological pathways of recurrent TTS. Lastly Singh, Akashi and Horowitz review the emerging treatment options for TTS. They issue also includes multiple elegant and fascinating case reports. TTS has come of age and now urgently adequate sized RCT’s.  </p>


2019 ◽  
Vol 10 (4) ◽  
pp. 277-286
Author(s):  
Jori E. Fleisher ◽  
Meghan M. Sweeney ◽  
Sarah Oyler ◽  
Talia Meisel ◽  
Naomi Friede ◽  
...  

BackgroundAs Parkinson disease (PD) progresses, symptoms increase, quality of life (QoL) declines, and individuals may become homebound, often losing access to neurologic care. We aimed to determine whether facilitating expert in-home care could improve our understanding of disease progression, treatment options, and unmet needs in this vulnerable population, and whether such a model could mitigate decline in QoL.MethodsPatients with PD meeting Medicare homebound criteria were eligible for quarterly interdisciplinary home visits over 12 months. Each visit entailed an evaluation by a movement disorders neurologist, social worker, and nurse, including history, examination, medication reconciliation, psychosocial evaluation, pharmacologic and nonpharmacologic management, and service referrals. Disease severity, as measured by the Unified Parkinson's Disease Rating Scale (UPDRS), and QoL using the Neuro-QoL were measured at visits 1 and 4.ResultsOf 27 enrolled patients, 23 completed 4 visits, with high retention and high patient- and caregiver-reported satisfaction. The mean age at baseline was 80.9 years (SD 7.8) with a mean total UPDRS of 65.0 (SD 20.0). After one year of home visits, total UPDRS worsened by a mean of 11.8 points (p < 0.01) without a change in any of 8 QoL domains (p = 0.19–0.95).ConclusionsHomebound individuals with advanced PD receiving interdisciplinary home visits experienced no significant decline in QoL over 1 year, despite disease progression. Our findings highlight the disease severity and impaired QoL of the advanced, homebound PD population, and the potential for novel approaches to foster continuity of care.


2019 ◽  
Vol 18 (1) ◽  
pp. 7
Author(s):  
Mario Bernardo-Filho

Dear all,It is my pleasure to introduce the BrazilianJournal of Health and Biomedical Sciences (BJHBS).The history of the Journal goes back to 1982, startingunder the title “Medicina HC-UERJ”. At that time, theJournal was created to be vehicle for the disseminationof experience, research, and didactic guidelines ofsubjects related to biomedical area of HUPE, theuniversity hospital of the State University of Rio deJaneiro (UERJ). The publication goes through somehardships from 1991 until 2001. Afterwards, in 2002,the Journal goes back to being published entitled as“Revista do Hospital Universitário Pedro Ernesto –UERJ”, HUPE Journal.In 2019, following actions towards expanding thescope of the Journal, the Editorial Board has decided toreview its title one more time, going for BJHBS. The aimof the Journal is to raise the quality of the publicationsand expand our network of international scientificcooperation. The Journal is also focused in promotingtranslation of basic research into clinical investigationand converting clinical evidence into practice. Theidea is to build strategies to improve health in differentlevels, from education to high technology.BJHBS is a multidisciplinary publication organizedto produce highly impactful articles. The editorialpolicy accepts articles covering a variety of themesin health and biomedical sciences with severalapproaches, if they are not in simultaneous analysisfor publication in any other journal. The Journalstrongly stimulates undergraduate and graduatestudents to submit papers sharing their scientificexperience abroad.The participation of the Associate Editors andthe Editorial Board is highly desired to expandBJHBS’ visibility in the scientific world. As part of thepublication ethics, the BJHBS promptly rejects anyplagiarism and self-plagiarism practices. It featuressections dedicated to original research, literaturereviews, case reports, and letters to the editor.Papers must be submitted in one of three languages:Portuguese, Spanish, and English.In this issue, papers with different approaches arepresented. There are studies in basic sciences and clinicalevaluations, as well as an article regarding occupationalexposures reported by patients with leukemia.You are welcome to contribute with a manuscriptin your area of expertise to BJHBS at any time.


Author(s):  
Megan Collins ◽  
Matthew Rivera

Context: Carpal bossing is a bony growth or mass that typically occurs at the 2nd or 3rd carpometacarpal joint. Carpal bossing is often overlooked placing the patient at an increased risk for pain or injury, such as osteoarthritis or inflammatory joint disease if left untreated. Individuals such as combat sport athletes who experience repetitive trauma to this area are at a high risk to develop carpal bossing. The literature suggests conservative or surgical interventions to manage symptoms. The goal of this systematic review is to synthesize the current literature for clinical knowledge and intervention outcomes for carpal bossing. Methods: A systematic search of the literature was performed across 3 electronic databases (Science Direct, PubMed, and EBSCOhost) to identify articles that investigated the effects of surgical intervention or conservative management for carpal bossing. A combination of the keywords and Boolean operators (Carpal Bossing, Carpal Boss, Surgical Intervention, Wedge Resection, Excision, Conservative Treatment, and Intervention) related to the research question were used. The search was restricted to full text, human studies (including cadaveric studies) research, and manuscripts available in English. Articles were included if they examined the effect of either conservative or surgical interventions for the treatment of carpal bossing. Articles were excluded from the review if the study did not examine carpal bossing treatment options or did not include pain, range of motion, strength, or functional measures of the hand and wrist. Two independent reviewers used the Joanna Briggs Institute Checklist for Case Reports and the Checklist for Case Studies to appraise the quality of the articles. A score of 50% was used to remove low-quality studies. The Strength of Recommendation Taxonomy (SORT) method was used to grade the evidence for the articles included. Results: After the initial search, 10 articles met the inclusion criteria, while 3 were eliminated due to low quality appraisal scores. The average scores for case reports and case studies were 5.5/7 or 7.5/9 respectively. There was a total of 58 participants across the 7 studies. Generally speaking, conservative treatment reduced average daily pain and patients were able to return to full participation within 2 weeks. Conversely, patients undergoing surgical intervention experienced episodic pain, including over the surgical incision, typically averaging 2/10 on the visual analog scale. Findings from the surgical intervention showed inconsistent measurements for wrist/hand strength and range of motion. There is level C evidence on the treatment for carpal bossing. Conclusion: The limited evidence suggests conservative management may reduce pain and improve clinical outcomes. However, clinicians should consider the level C evidence with skepticism as the quality of evidence on this topic is low. Further investigations should be performed with more rigor.


Sign in / Sign up

Export Citation Format

Share Document